
Poor Outcomes of Hospitalized COVID-19 Patients with Type 2 Diabetes and Chronic Kidney Disease
This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE)

This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE)

This paper was presented on May 12th at the 30thAnnual Meeting of the American Association of Clinical Endocrinology (AACE) at

This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE)

This paper was presented on May 12th at the 30th Annual Meeting of the American Association of Clinical Endocrinology (AACE)
One of the central themes of physicians’ professional lives this past year has been the lack of certainty when addressing
In developing countries, depressive symptoms are common in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D), particularly
Although a diagnosis of type 1 diabetes (T1D) should not limit a person’s ability to compete at the highest level